Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

acyclovir sodium

ACYCLOVIR SODIUM

acyclovir sodium (ACYCLOVIR SODIUM) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 19
Pipeline programs 31
News articles 0
Drug details — acyclovir sodium
US status
approved
Class
—
Route
INJECTION
Patents
19
Programs
31
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

acyclovir sodium (ACYCLOVIR SODIUM) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN acyclovir sodium
Brand ACYCLOVIR SODIUM
Mechanism Human herpesvirus 1 DNA polymerase inhibitor
Target DNA polymerase catalytic subunit
Route INJECTION
Formulation INJECTABLE
Originator Teva Pharma GmbH

Mechanism of action

Human herpesvirus 1 DNA polymerase inhibitor

Primary target: DNA polymerase catalytic subunit

Approval history

Authority Status Date
FDA approved —

Pipeline programs

Search pipeline Sponsor programs
  1. 0.9% Sodium Chloride Solution, Glenzocimab Phase 3 · PARItec · Acute ischemic stroke
  2. 0.9% Sodium Chloride, JNJ-78901563 Phase 3 · Zhejiang Xianju Pharmaceutical · Invasive Extraintestinal Pathogenic Escherichia coli Disease
  3. 0.9% sodium chloride, GB-0895 Phase 3 · Generate Biomedicines · severe uncontrolled asthma
  4. 0.9% sodium chloride, Lepodisiran Phase 3 · Eli Lilly and · Atherosclerotic Cardiovascular Disease Elevated lp(a)
  5. 213823 Phase 3 · GSK Glaxo Smith · Lung Cancer, Non-Small Cell
  6. 299IG301 Phase 3 · Biogen · IgA nephropathy
  7. ACE-536-MF-002 Phase 3 · Celgene · Anemia associated with myeloproliferative neoplasm (MPN)-ass
  8. ALN-AGT01-008 Phase 3 · Alnylam Netherlands · High cardiovascular risk, Established cardiovascular disease

Related & competitor drugs

Browse all drugs
  1. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  2. famciclovir Human herpesvirus 1 DNA polymerase inhibitor
  3. foscarnet sodium Human herpesvirus 1 DNA polymerase inhibitor
  4. ganciclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  5. penciclovir Human herpesvirus 1 DNA polymerase inhibitor
  6. valacyclovir hydrochloride Human herpesvirus 1 DNA polymerase inhibitor

Related patents

Browse patents Teva Pharma GmbH patent hub

  1. WO 2026112397

    COMPOSITIONS ET PROCÉDÉS DE PRODUCTION DE VIRUS ADÉNO-ASSOCIÉS

    Expires Wed May 23 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. WO 2026085433

    PROCÉDÉS POUR PRÉPARER DES CONJUGUÉS OLIGONUCLÉOTIDIQUES

    Expires Wed Apr 18 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2026060131

    ADDITIFS POUR LA PRODUCTION DE VECTEURS VIRAUX

    Expires Wed Mar 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2026055127

    PROCÉDÉ DE PRODUCTION D'UN MODULATEUR DE RÉCEPTEUR GABA

    Expires Wed Mar 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. WO 2025165930

    MÉTHODES DE TRAITEMENT DE L'AMYOTROPHIE SPINALE

    Expires Wed Aug 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. WO 2025111408

    COMPOSÉS POUR LE TRAITEMENT DE L'AMYOTROPHIE SPINALE ET DE LA MALADIE DE HUNTINGTON

    Expires Thu May 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. WO 2025111409

    COMPOSÉS HÉTÉROCYCLIQUES DE FORMULE (I) DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE L'AMYOTROPHIE SPINALE PAR MODULATION DE L'ÉPISSAGE DE SMN2

    Expires Thu May 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. WO 2025106633

    INHIBITEURS DE TYK2

    Expires Wed May 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. WO 2025049275

    INHIBITEURS DE LA PROTÉINE DE LIAISON À L'ÉMOPAMIL ET LEURS UTILISATIONS

    Expires Wed Mar 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. WO 2025043148

    INHIBITEURS DE PROTÉINE DE LIAISON À L'ÉMOPAMIL ET LEURS UTILISATIONS

    Expires Wed Feb 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. WO 2025038863

    DÉRIVÉS D'INDOLE ET DE PYRROLOYPYRIDINE UTILISÉS EN TANT QUE MODULATEURS DE GPR17

    Expires Wed Feb 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. WO 2024259178

    INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE 3 ET LEURS UTILISATIONS

    Expires Wed Dec 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. WO 2024233374

    COMBINAISON D'UN INHIBITEUR DE BTK ET D'UN ESTER D'ACIDE FUMARIQUE DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES

    Expires Wed Nov 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. WO 2024233379

    INHIBITEUR DE BTK POUR LE TRAITEMENT DE LA SCLÉROSE EN PLAQUES

    Expires Wed Nov 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. WO 2024216080

    RÉGIMES IMMUNOSUPPRESSEURS ET PROCÉDÉS ASSOCIÉS

    Expires Wed Oct 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 6849736

    Crystalline forms of valacyclovir hydrochloride

    Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6849737

    Synthesis and purification of valacyclovir

    Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6214811

    Acyclovir diester derivatives

    Expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6031096

    Acyclovir diester derivatives

    Expires Mon Feb 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is acyclovir sodium?

acyclovir sodium (ACYCLOVIR SODIUM) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for acyclovir sodium?

ACYCLOVIR SODIUM is a marketed brand name for acyclovir sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of acyclovir sodium?

acyclovir sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.